These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8264290)

  • 21. Effects of toquipidine on ionic channels of cultured embryonic Xenopus laevis myoblasts and neurons.
    Zheng P; Chen G; Shi NC; Zhou SP; Lu YQ; Yao MH; He ZY
    Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):427-39. PubMed ID: 8701760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cardiac sodium channel: a target for antiarrhythmic drug action.
    Grant AO
    Pacing Clin Electrophysiol; 1990 Nov; 13(11 Pt 2):1541-52. PubMed ID: 1702535
    [No Abstract]   [Full Text] [Related]  

  • 23. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation.
    Aoike F; Takahashi MP; Sakoda S
    Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Class I antiarrhythmic drugs: allosteric inhibitors of [3H] batrachotoxinin binding to rat cardiac sodium channels.
    Sheldon RS; Duff HJ; Thakore E; Hill RJ
    J Pharmacol Exp Ther; 1994 Jan; 268(1):187-94. PubMed ID: 8301556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current classification of anti-arrhythmia agents].
    Weirich J; Wenzel W
    Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology and classification of antiarrhythmic drugs.
    MacFadyen RJ; Prasad N
    Br J Hosp Med; 1995 Nov 15-Dec 12; 54(10):515-9. PubMed ID: 8574495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The clinical pharmacology of anti-arrhythmia drugs].
    Viktorov AP
    Vrach Delo; 1991 Apr; (4):3-9. PubMed ID: 2063560
    [No Abstract]   [Full Text] [Related]  

  • 28. The pharmacology of voltage-gated sodium channels in sensory neurones.
    Docherty RJ; Farmer CE
    Handb Exp Pharmacol; 2009; (194):519-61. PubMed ID: 19655117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The classification of antiarrhythmic drugs].
    Iinuma H
    Nihon Rinsho; 1996 Aug; 54(8):2104-9. PubMed ID: 8810784
    [No Abstract]   [Full Text] [Related]  

  • 30. NA+- and K+-channels as molecular targets of the alkaloid ajmaline in skeletal muscle fibres.
    Friedrich O; V Wegner F; Wink M; Fink RH
    Br J Pharmacol; 2007 May; 151(1):82-93. PubMed ID: 17351660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Block of NA+ and K+ currents in rat ventricular myocytes by quinacainol and quinidine.
    Pugsley MK; Walker MJ; Saint DA
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):60-5. PubMed ID: 15730436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-adrenergic stimulation modulates the sodium current block by propafenone in rat ventricular myocardium.
    Maier SK; Kirstein M
    J Electrocardiol; 2002 Oct; 35(4):343-9. PubMed ID: 12395362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Proarrhythmic effects of anti-arrhythmia agents].
    Enrico JF; Kehtari R
    Rev Med Suisse Romande; 1998 Aug; 118(8):671-90. PubMed ID: 9838826
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of propafenone in paramyotonia congenita.
    Alfonsi E; Merlo IM; Tonini M; Ravaglia S; Brugnoni R; Gozzini A; Moglia A
    Neurology; 2007 Mar; 68(13):1080-1. PubMed ID: 17389319
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of antiarrhythmic drugs.
    Henahan SK
    CRNA; 1996 Feb; 7(1):47-51. PubMed ID: 8680355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classification and pharmacology of antiarrhythmic drugs.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha DB
    Am Heart J; 2000 Jul; 140(1):12-20. PubMed ID: 10874257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-arrhythmia agents].
    Bracchi G; Vezzoli F
    Clin Ter; 1976 Jul; 78(1):65-85. PubMed ID: 1009752
    [No Abstract]   [Full Text] [Related]  

  • 38. Negative dromotropic effects of class I antiarrhythmic drugs in anisotropic ventricular muscle.
    Iida M; Kodama I; Toyama J
    Cardiovasc Res; 1996 Apr; 31(4):640-50. PubMed ID: 8689657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse.
    De Luca A; Pierno S; Liantonio A; Desaphy JF; Natuzzi F; Didonna MP; Ferrannini E; Jockusch H; Franchini C; Lentini G; Corbo F; Tortorella V; Camerino DC
    Neuromuscul Disord; 2004 Jul; 14(7):405-16. PubMed ID: 15210163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents].
    Tuna JL
    Rev Port Cardiol; 1992 Apr; 11(4):385-6. PubMed ID: 1632995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.